secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-10-21T23:59:59+00:00
Accession:  0001628280-25-045731
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Solventum appoints Heather Knight as Chief Commercial Officer; Chris Barry to depart
--------------------------------------------------------------------------------

- Heather Knight appointed to new Chief Commercial Officer role effective Nov 10, 2025, overseeing MedSurg, Dental, Health Information Systems.
- Ms. Knight previously COO at Baxter International; brings 30+ years MedTech leadership.
- Chris Barry, EVP & Group President of MedSurg, will depart Dec 31, 2025, and receive severance under the Solventum Executive Severance Plan.
- Knight will report directly to CEO Bryan Hanson.
- Barry's outstanding equity awards will be treated per applicable agreements and Severance Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000162828025045731/0001628280-25-045731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000162828025045731/solv-20251017.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-045731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer